Taken together, findings from this large prospective study of survival in HIV-infected patients suggest that maintaining higher CD4+ T-cell counts is a key factor to improve prognosis after both ADCs and NADCs, in particular when considering Kaposi sarcoma and the lymphomas. This evidence concerns the gene CD4 and lymphoma.